Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

医学 肝细胞癌 外科肿瘤学 内科学 单变量分析 外科 肝硬化 阶段(地层学) 肝癌 多元分析 生物 古生物学
作者
Lan‐Qing Yao,Zhengliang Chen,Zihan Feng,Yong‐Kang Diao,Chao Li,Haiying Sun,Jian‐Hong Zhong,Ting‐Hao Chen,Wei‐Min Gu,Ya-Hao Zhou,Wanguang Zhang,Hong Wang,Yongyi Zeng,Han Wu,Ming-Da Wang,Xin‐Fei Xu,Timothy M. Pawlik,Wan Yee Lau,Feng Shen,Tian Yang
出处
期刊:Annals of Surgical Oncology [Springer Science+Business Media]
卷期号:29 (7): 4291-4303 被引量:85
标识
DOI:10.1245/s10434-022-11454-y
摘要

BackgroundA potentially curative hepatic resection is the optimal treatment for hepatocellular carcinoma (HCC), but most HCCs, even at an early stage, eventually recur after resection. This study investigates clinical features of initial recurrence and long-term prognosis of patients with recurrence after curative resection for early-stage HCC.Patients and MethodsFrom a multicenter database, patients who underwent curative hepatic resection for early-stage HCC [Barcelona Clinic Liver Cancer (BCLC) stage 0/A] were extracted. Time to initial recurrence, patterns of initial recurrence, and treatment modalities for recurrent tumors were investigated. Univariate and multivariate analysis were used to identify independent risks associated with postoperative recurrence, as well as post-recurrence survival (PRS) for patients with recurrence.ResultsAmong 1424 patients, 679 (47.7%) developed recurrence at a median follow-up of 54.8 months, including 408 (60.1%) early recurrence (≤ 2 years after surgery) and 271 (39.9%) late recurrence (> 2 years). Independent risks of postoperative recurrence included cirrhosis, preoperative alpha-fetoprotein level > 400 ug/L, tumor size > 5 cm, multiple tumors, satellites, microvascular invasion, and intraoperative blood transfusion. Multivariate analysis revealed that receiving irregular recurrence surveillance, initial tumor beyond Milan criteria, early recurrence, BCLC stage B/C of the recurrent tumor, and noncurative treatments were independently associated with poorer PRS.ConclusionsNearly half of patients with early-stage HCC experienced recurrence after resection. Understanding recurrence risks may help identify patients at high risk of recurrence who may benefit from future adjuvant therapies. Meaningful survival even after recurrence can still be achieved by postoperative regular surveillance and curative treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cheche完成签到,获得积分10
刚刚
WHY完成签到,获得积分10
1秒前
1秒前
拼搏菲鹰完成签到,获得积分10
1秒前
畅快的绮菱完成签到,获得积分10
2秒前
过时的访梦完成签到,获得积分20
2秒前
1501929468完成签到,获得积分10
2秒前
Su发布了新的文献求助10
2秒前
配你zzz发布了新的文献求助10
2秒前
3秒前
jhwang完成签到,获得积分10
3秒前
冲锋的白完成签到,获得积分10
3秒前
3秒前
Jameson完成签到,获得积分10
3秒前
Gladys发布了新的文献求助10
4秒前
光亮芷天完成签到,获得积分10
4秒前
眼睛大又蓝完成签到,获得积分10
6秒前
王小磊完成签到,获得积分10
6秒前
6秒前
6秒前
6秒前
乐乐应助科研通管家采纳,获得10
7秒前
孟春纪事发布了新的文献求助10
7秒前
molihuakai应助科研通管家采纳,获得10
7秒前
共享精神应助科研通管家采纳,获得10
7秒前
JamesPei应助科研通管家采纳,获得10
7秒前
Kevin丶大牛完成签到,获得积分10
7秒前
7秒前
7秒前
ffrrss应助科研通管家采纳,获得10
7秒前
Lucas应助科研通管家采纳,获得10
7秒前
SciGPT应助科研通管家采纳,获得10
7秒前
shanshan完成签到,获得积分10
8秒前
大个应助科研通管家采纳,获得10
8秒前
打打应助科研通管家采纳,获得10
8秒前
FashionBoy应助科研通管家采纳,获得10
8秒前
wy.he应助科研通管家采纳,获得50
8秒前
曾小莹发布了新的文献求助10
8秒前
尊敬寒松完成签到 ,获得积分10
8秒前
科研通AI6.2应助幽默帽子采纳,获得10
8秒前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
久松真一著作集〈第5巻〉禅と芸術 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6555791
求助须知:如何正确求助?哪些是违规求助? 8340026
关于积分的说明 17867426
捐赠科研通 5673712
什么是DOI,文献DOI怎么找? 2940398
邀请新用户注册赠送积分活动 1916238
关于科研通互助平台的介绍 1786623